Literature DB >> 7410213

Hygromycin and epihygromycin from a bacterium, Corynebacterium equi No. 2841.

Y Wakisaka, K Koizumi, Y Nishimoto, M Kobayashi, N Tsuji.   

Abstract

A newly isolated bacterium which produces antibacterial substances as below was taxonomically characterized and identified with Corynebacterium equi. The major antibiotic produced was determined to be hygromycin by direct comparison. The minor component, newly named epihygromycin was proved to be an epimer of hygromycin by spectrosocopic evidences and by chemical conversions. The presence of epihygromycin in the metabolites of Streptomyces noboritoensis (reported to be a hygromycin producer) was also observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410213     DOI: 10.7164/antibiotics.33.695

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

1.  Construction of an Escherichia coli-Rhodococcus shuttle vector and plasmid transformation in Rhodococcus spp.

Authors:  M E Singer; W R Finnerty
Journal:  J Bacteriol       Date:  1988-02       Impact factor: 3.490

Review 2.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

3.  Terfestatins B and C, New p-Terphenyl Glycosides Produced by Streptomyces sp. RM-5-8.

Authors:  Xiachang Wang; Anna R Reynolds; Sherif I Elshahawi; Khaled A Shaaban; Larissa V Ponomareva; Meredith A Saunders; Ibrahim S Elgumati; Yinan Zhang; Gregory C Copley; James C Hower; Manjula Sunkara; Andrew J Morris; Madan K Kharel; Steven G Van Lanen; Mark A Prendergast; Jon S Thorson
Journal:  Org Lett       Date:  2015-05-11       Impact factor: 6.005

4.  Distinct tRNA Accommodation Intermediates Observed on the Ribosome with the Antibiotics Hygromycin A and A201A.

Authors:  Yury S Polikanov; Agata L Starosta; Manuel F Juette; Roger B Altman; Daniel S Terry; Wanli Lu; Benjamin J Burnett; George Dinos; Kevin A Reynolds; Scott C Blanchard; Thomas A Steitz; Daniel N Wilson
Journal:  Mol Cell       Date:  2015-05-28       Impact factor: 17.970

Review 5.  Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.

Authors:  Jinzhong Lin; Dejian Zhou; Thomas A Steitz; Yury S Polikanov; Matthieu G Gagnon
Journal:  Annu Rev Biochem       Date:  2018-03-23       Impact factor: 27.258

6.  Genomic and Secondary Metabolite Analyses of Streptomyces sp. 2AW Provide Insight into the Evolution of the Cycloheximide Pathway.

Authors:  Elizabeth R Stulberg; Gabriel L Lozano; Jesse B Morin; Hyunjun Park; Ezra G Baraban; Christine Mlot; Christopher Heffelfinger; Gillian M Phillips; Jason S Rush; Andrew J Phillips; Nichole A Broderick; Michael G Thomas; Eric V Stabb; Jo Handelsman
Journal:  Front Microbiol       Date:  2016-05-03       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.